Silver Nanoparticle-Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in Escherichia coli, Salmonella Enteritidis and Staphylococcus aureus.

Antibiotics (Basel) · 2025 · PMC12562104 · PMID 41148652

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Nevertheless, consistent with the results observed in the dye uptake assay, treatments with Bio-AgNP, C1, and C2 showed a trend toward increased leakage for both biomolecules, with numerically higher values compared to their respective control groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Silver Nanoparticle-Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in &lt;i&gt;Escherichia coli&lt;/i&gt;, &lt;i&gt;Salmonella&lt;/i&gt; Enteritidis and &lt;i&gt;Staphylococcus aureus&lt;/i&gt;.

The sentences

Silver Nanoparticle-Antibiotic Combinations: A Strategy to Overcome Bacterial Resistance in <i>Escherichia coli</i>, <i>Salmonella</i> Enteritidis and <i>Staphylococcus aureus</i>.